logo


You're contacting media contact of this press release

Title: Cornell AgriTech Field Trials Validate GotaBlanca's Broad-Spectrum Performance for Safe Pathogen Control Across Key Vegetable Crops in the USA

Costa Rica, 26th Feb 2026 —ClearLeaf, a Costa Rican agricultural technology company specializing in safe pathogen control, today announced exceptional results from field trials conducted by Cornell University's Cornell AgriTech. The trials evaluated GotaBlanca's efficacy in controlling major diseases in vegetable crops. They expand upon previous successful apple and grape trials, further validating GotaBlanca's broad-spectrum capabilities in the United States and demonstrating the technology's versatility across diverse agricultural systems, including row crops.The trials, conducted by Dr. Sarah J. Pethybridge and her team at Cornell AgriTech's Plant Pathology and Plant-Microbe Biology Section in Geneva, New York, evaluated GotaBlanca across multiple diseases in watermelon, table beet, and sweet corn during the 2025 growing season. The results demonstrated that GotaBlanca not only provides effective disease control but also enhances overall plant health and productivity, aligning with regenerative agriculture principles that prioritize crop performance, environmental sustainability and farmer and consumer health.Targeting anthracnose in watermelonsIn watermelon trials targeting anthracnose, a devastating fungal disease, GotaBlanca achieved excellent disease control while producing the heaviest individual fruits among all treatments, including conventional fungicides. Treated watermelons weighed substantially more than controls, demonstrating that its effective pathogen management enhances rather than compromises crop productivity. Controlling bacterial diseases in table beetsIn trials involving table beets, GotaBlanca demonstrated excellent control of bacterial diseases that can severely reduce crop quality and yield. GotaBlanca treatments consistently produced sup...


This press release is issued by King Newswire

Email Information